Clinical trial Recruiting at 1 site Interventional Ages 14 to 35

Graded exposure and mindfulness meditation for patients recovering from ACL reconstruction

Official title: The GEMM Trial: Graded Exposure and Mindfulness Meditation for Patients Post- ACL Reconstruction

Run by University of North Carolina, Chapel Hill · NCT05949177 · Data updated 2026-11-12

This study is testing if a combination of mindfulness meditation and graded exposure can help young adults who have had ACL surgery feel less anxious and improve their reaction time during recovery.

More Anterior Cruciate Ligament Injuries trials

Quick facts

Study typeInterventional
Ages14 Years to 35 Years
SexAll
Enrollment50 (estimated)
SponsorUniversity of North Carolina, Chapel Hill
Academic / other
Locations1 site (Chapel Hill, North Carolina)
StatusRecruiting
StartedOctober 30, 2024
Main results expectedJuly 31, 2027
Study endsJuly 31, 2027
Registry record updatedNovember 3, 2026
Trial IDNCT05949177 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 18-25 years who have undergone unilateral ACL reconstruction and report elevated levels of injury-related fear.

Probably not a fit

Patients with a history of secondary ACL injury or those who do not exhibit elevated injury-related fear may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of a combined approach of graded exposure and mindfulness meditation in reducing injury-related fear and anxiety, as well as improving reaction time in individuals who have undergone anterior cruciate ligament reconstruction (ACLR). Participants aged 18-25 years, who are 1 to 5 years post-ACLR, will be randomized into either the intervention group receiving the GEMM program or a waitlist control group. The intervention will be delivered through the Headspace application over a 5-week period, with assessments conducted before and after the intervention to measure outcomes related to fear, anxiety, and reaction time. The study aims to provide insights into the feasibility and efficacy of integrating mindfulness practices into rehabilitation for ACL injuries.

Why it matters

Potential benefit: If successful, this approach could significantly reduce fear and anxiety related to reinjury, enhancing recovery and performance for young athletes post-ACLR.

How similar studies have gone: While graded exposure and mindfulness meditation have shown promise individually, this combined approach has not been extensively tested in the context of ACL rehabilitation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ages 14-35 years
* Have self-reported levels of fear on the Tampa Scale of Kinesiophobia-11 and the Photographic Series of Sports Activities for ACLR
* Injured their knee playing or training for sports (recreational or organized)
* Have a history of unilateral ACLR
* 6 months to 10-years post-ACLR

Exclusion Criteria:

* History of secondary ACL injury
* Do not exhibit elevated injury-related fear
* Concomitant surgeries at the time of ACL reconstruction

Where it's running

  • Woollen Gymnasium, 300 South Road
    Chapel Hill, North Carolina, United States
    Recruiting

Study contacts

  • Principal investigator: Shelby E Baez, Ph.D., ATC — UNC-Chapel Hill
  • Study coordinator: Shelby E Baez, Ph.D., ATC
  • Email: sbaez@unc.edu
  • Phone: 919-445-1500

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.